Key Takeaways
- Ruminant Biotech begins a C$7.6 million research program in Alberta.
- Program supported by a C$2.8 million grant from Emissions Reduction Alberta.
- Research aims to validate methane-reducing bolus for pasture-based cattle.
- Initiative supports product registration and future commercialization in Canada.
- Company establishes North American base in Calgary to support expansion.
Ruminant Biotech Advances Canadian Research Initiative
Ruminant Biotech has announced the launch of a C$7.6 million research program focused on validating its methane mitigation solution for pasture-based cattle. The initiative is supported by a C$2.8 million grant from the Government of Alberta through Emissions Reduction Alberta (ERA), along with additional co-funding from industry partners.
The research program marks Ruminant Biotech’s first expansion beyond Australasia. Beginning in August, the company will collaborate with Alberta-based colleges, universities, and federal research facilities to generate data required for product registration and commercialization in Canada.
Tom Breen, CEO of Ruminant Biotech, said the program is designed to demonstrate the effectiveness of the company’s methane reduction solution across Alberta’s beef herd and support regulatory approval for commercial use.
Ruminant Biotech's Technology Designed for Pasture-Based Livestock
Ruminant Biotech’s solution consists of an orally administered, slow-release bolus that resides in the rumen and inhibits methane production. The company reports that more than 25 animal trials conducted in New Zealand and Australia have indicated methane reductions of approximately 75% for over 100 days following a single application.
Canada’s cattle sector includes approximately 11 million animals, which collectively account for a significant share of the country’s methane emissions. The company states that the new research program will provide on-farm data related to safety and effectiveness under Canadian conditions.
Expansion Strategy and North American Presence
As part of its expansion strategy, Ruminant Biotech will establish its North American headquarters in Calgary to oversee operations in Canada and the United States. The company has received 41 letters of support and is collaborating with organizations including Olds College, Calgary Economic Development, and Agriculture and Agri-Food Canada.
Ruminant Biotech reports that it has secured approximately C$9 million in grant funding to date. The current program is intended to support regulatory approval processes in Canada and lay groundwork for potential future expansion into the United States, Brazil, and the European Union.
The company indicated it remains open to engaging with additional partners and investors as the research progresses.
